Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY:ABT)

105.53 -0.08 (-0.08%)
Streaming Delayed Price Updated: 1:45 PM EDT, Jul 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
57 58 Next >
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Dexcom Earnings Tops Estimates, Medical Device Maker Hikes Outlook ↗
Dexcom stock rose after the company reported Q2 earnings and revenue that topped Wall Street targets and raised full-year sales guidance. 
Via Investor's Business Daily
News headline image
Chronic Pain Specialist Speaks At Panel On Stem Cell-Based Therapies And The Need For Spinal Care Reform – Insights From The Discussion ↗
Chronic back pain is a significant issue in the United States, affecting millions of individuals annually. 
Via Benzinga
News headline image
Abbott Recalls Amplatzer Steerable Delivery Sheath On Risk Of Air Embolism ↗
Abbott Laboratories (NYSE: ABT) is recalling the Amplatzer Steerable Delivery Sheath due to an increased  
Via Benzinga
News headline image
Looking Into Abbott Laboratories's Recent Short Interest ↗
 
Via Benzinga
News headline image
Looking At Abbott Laboratories's Recent Unusual Options Activity ↗
 
Via Benzinga
News headline image
Abbott Laboratories (ABT) Q2 2023 Earnings Call Transcript ↗
ABT earnings call for the period ending June 30, 2023. 
Via The Motley Fool
News headline image
Abbott Stock Edges Higher As Earnings Decline But Still Top Forecasts ↗
The company continues to expect some Covid sales this year, but cut its outlook. 
Via Investor's Business Daily
News headline image
Abbott Laboratories's Earnings Outlook ↗
 
Via Benzinga
News headline image
2 Top Dividend Stocks to Buy and Hold Forever ↗
They have been paying dividends for a long time. 
Via The Motley Fool
News headline image
Russia Is Seizing European Company Assets — What US Businesses Are Still At Risk? ↗
 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
What's In Store For Abbott Laboratories In Q2 Earnings? ↗
Abbott Laboratories is slated to report second-quarter 2023 results on July 20 before the market opens. 
Via Talk Markets
News headline image
Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years ↗
 
Via Benzinga
News headline image
(ABT) - Analyzing Abbott Laboratories's Short Interest ↗
 
Via Benzinga
News headline image
3 Ultrareliable Dividend Stocks to Buy and Hold for Decades ↗
These stocks have decades of annual dividend raises under their belts, and rising healthcare costs mean there could be plenty more to come. 
Via The Motley Fool
News headline image
Apple To Rally Over 17%? Here Are 10 Other Analyst Forecasts For Monday ↗
Citigroup raised the price target for Cintas Corporation (NASDAQ: CTAS) from $540 to $550. Citigroup analyst Leo Carrington downgraded the stock from Buy to Neutral. Cintas shares fell 0.8% to $503.43... 
Via Benzinga
News headline image
Abbott's Higher Than Expected Q2 Earnings: Analyst Foresees Strong Performance In 2024 ↗
Thursday, Abbott Laboratories (NYSE: ABT) reported better-than-expected Q2 earnings. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 21, 2023 ↗
 
Via Benzinga
News headline image
Dow Jones Leads Market Advance As Tesla, Netflix, Taiwan Semiconductor Hit Growth: Weekly Review ↗
But all the major indexes are at or near 15-month highs. 
Via Investor's Business Daily
News headline image
J&J, Abbott Labs And JPM Among Jim Cramer's Top Picks As Market Shifts Focus From Tech ↗
 
Via Benzinga
News headline image
Johnson & Johnson's Inflection Point: What it Means for Investors
Johnson & Johnson stock and the company show signs of strength and growth while offering value and yield relative to its peer Abbott Laboratories. 
Via MarketBeat
News headline image
Abbott Laboratories Has the Prescription for Higher Share Prices
Abbott Laboratories stock is ready to rebound after a year of correction. The decline of COVID is priced into the market, and organic growth is accelerating. 
Via MarketBeat
News headline image
Tesla Recalls Over 17K EVs Over Camera & Seat Belt Issues, University Research Uncovers Unexpected Fluctuations In ChatGPT Capabilities, Juul Seeks FDA Nod For Next-Generation Vaporizer: Today's Top Stories ↗
Benzinga Tesla Recalls More Than 17,000 EVs Over Camera, Seat Belt Issues 
Via Benzinga
News headline image
Abbott Laboratories Clocks Strong Q2 Growth In Underlying Base Business, Reaffirms FY23 Outlook ↗
Abbott Laboratories (NYSE: ABT) has reported Q2 FY23 adjusted EPS of $1.08, down 25% Y/Y, beating the consensus of $1.05. 
Via Benzinga
News headline image
Johnson & Johnson, Tesla And 3 Stocks To Watch Heading Into Thursday ↗
With U.S. stock futures trading lower this morning on Thursday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
News headline image
Markets Remain Bullish After Dow Rises For Eighth Consecutive Session ↗
The CNN Money Fear and Greed index remained in the "Extreme Greed" zone on Wednesday. The Dow Jones gained recorded gains for the eighth straight session on Wednesday, its longest winning streak since... 
Via Benzinga
News headline image
Earnings Scheduled For July 20, 2023 ↗
Companies Reporting Before The Bell • Taiwan Semiconductor (NYSE:TSM) is estimated to report quarterly earnings at $1.08 per share on revenue of $15.49 billion. 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Abbott Scores FDA Nod For First Dual-Chamber Leadless Pacemaker To Treat Abnormal, Slow Heart Rhythms ↗
The FDA has approved Abbott Laboratories' (NYSE: ABT) AVEIR dual chamber (DR) leadless pacemaker system, the world's first dual chamber leadless pacing system to treat  
Via Benzinga
< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
57 58 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.